Eli Lilly's $6B Alabama Plant for Weight-Loss Drugs

Eli Lillys shares have soared nearly thirty percent this year, outpacing the market, driven by high demand for weight-loss medications. The company is investing six billion dollars in a new plant in Huntsville, Alabama, to manufacture various drugs, including its experimental weight-loss pill, orforglipron. This move follows a deal with the White House to lower prices and increase domestic production, securing tariff relief and price mandate assurances. The facility will utilize advanced technologies like machine learning and AI, reflecting a broader trend of pharmaceutical companies boosting American production.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.